Chiba, Japan

Eisaku Yoshida

USPTO Granted Patents = 3 


Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Kashiwa, JP (2015)
  • Chiba, JP (2018)
  • Tokyo, JP (2022)

Company Filing History:


Years Active: 2015-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Eisaku Yoshida

Introduction

Eisaku Yoshida is a notable inventor based in Chiba, Japan, recognized for his significant contributions to the field of medical diagnostics. With a total of three patents to his name, Yoshida has focused on developing methods that enhance the diagnosis and monitoring of serious health conditions.

Latest Patents

Yoshida's latest patents include groundbreaking methods for diagnosing hepatocellular carcinoma and pancreatic cancer. These patents disclose biomarkers such as laminin gamma 2 monomer, PIVKA-II, AFP, CEA, and CA19-9, which can be used to diagnose, prognose, classify risk, and monitor the progression of these cancers. Additionally, he has developed immunoassay methods and reagents aimed at reducing nonspecific binding in tests for PIVKA-II, utilizing various additives to improve accuracy.

Career Highlights

Throughout his career, Yoshida has worked with prominent companies, including Abbott Japan LLC and Abbott Laboratories Corporation. His work has significantly impacted the field of cancer diagnostics, showcasing his commitment to advancing medical technology.

Collaborations

Yoshida has collaborated with esteemed colleagues such as Toru Yoshimura and Barry Lee Dowell, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Eisaku Yoshida's innovative work in medical diagnostics exemplifies the vital role of inventors in advancing healthcare technology. His contributions continue to influence the methods used in diagnosing critical diseases, ultimately benefiting patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…